Verapamil

• 

  Subject Areas on Research

  • A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. 
  • Ability of epinephrine, but not increased extracellular calcium, to reverse the effects of verapamil on ventricular automaticity in vitro. 
  • Activating PKC-β1 at the blood-brain barrier reverses induction of P-glycoprotein activity by dioxin and restores drug delivery to the CNS. 
  • Activation of PKC isoform beta(I) at the blood-brain barrier rapidly decreases P-glycoprotein activity and enhances drug delivery to the brain. 
  • Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture. 
  • Calcium channel blockers and mortality in elderly patients with myocardial infarction. 
  • Cell surface expression of major histocompatibility class I antigens is modulated by P-glycoprotein transporter. 
  • Central Ca++-channel blockade reverses ethanol-induced poikilothermia in the rat. 
  • Characterization of the energy-dependent, mating factor-activated Ca2+ influx in Saccharomyces cerevisiae. 
  • Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. 
  • Compatibility of aminophylline and verapamil in intravenous admixtures. 
  • Decreased alcohol consumption by verapamil in alcohol preferring rats. 
  • Differences in the absorption, metabolism and biliary excretion of a diastereomeric pair of alphavbeta3-antagonists in rat: limited role of P-glycoprotein. 
  • Differential effect of HERG blocking agents on cardiac electrical alternans in the guinea pig. 
  • Divergent action of verapamil perfused in two hypothalamic areas on body temperature of the cat. 
  • Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats. 
  • Effect of calcium-channel blockers on alcohol consumption in alcohol-drinking monkeys. 
  • Effect of verapamil on left ventricular function at rest and during exercise in normal men. 
  • Effect of verapamil on submissive behavior in genetically bred hypercholinergic rats in a water competition test. 
  • Effects of verapamil on postextrasystolic potentiation. 
  • Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial). 
  • Existence of both fast and slow channel activity during the early stages of ventricular fibrillation. 
  • Extracellular Ca2+ mobilization in potential-dependent contraction of trachealis of maturing swine. 
  • Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. 
  • Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. 
  • Intracellular potassium activity in rabbit sinoatrial node. Evaluation during spontaneous activity and arrest. 
  • Ion channel inhibition against COVID-19: A novel target for clinical investigation. 
  • Is it safe to use intravenous verapamil to treat a patient who is taking oral verapamil? 
  • Licorice-associated reversible cerebral vasoconstriction with PRES. 
  • Life-table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia. 
  • Limiting impairment of muscle function following ischemia and reperfusion in rabbits. 
  • Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow. 
  • Neuroanatomical mapping of hypothalamic regions mediating verapamil hyper- and hypothermia in the cat. 
  • Nifedipine in severely hypertensive patients with congestive heart failure and preserved ventricular systolic function. 
  • P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine). 
  • Pulmonary edema post-cardioversion: a potential calcium signalling problem. 
  • Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome. 
  • Rapid, reversible modulation of blood-brain barrier P-glycoprotein transport activity by vascular endothelial growth factor. 
  • Rate of in vivo verapamil exchange within the hypothalamus of the cat as examined by push-pull perfusion. 
  • Reduction of spontaneous alcohol drinking and physical withdrawal by levemopamil, a novel Ca2+ channel antagonist, in rats. 
  • Safety and feasibility of renal blood flow determination during kidney transplant surgery with perfusion ultrasonography. 
  • Severe theophylline toxicity. Role of conservative measures, antiarrhythmic agents, and charcoal hemoperfusion. 
  • T-tubule depolarization-induced SR Ca2+ release is controlled by dihydropyridine receptor- and Ca(2+)-dependent mechanisms in cell homogenates from rabbit skeletal muscle. 
  • Targeting blood-brain barrier sphingolipid signaling reduces basal P-glycoprotein activity and improves drug delivery to the brain. 
  • The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. 
  • The effect of endothelin-1 on muscle microcirculation and its attenuation by verapamil. 
  • The role of calcium in the regulation of prostacyclin synthesis by porcine aortic endothelial cells. 
  • The spontaneous occurrence of paroxysmal supraventricular tachycardia. 
  • Theophylline produces an adverse effect on myocardial lactate metabolism at a therapeutic serum concentration: an effect blocked by verapamil. 
  • Transport of polypeptide ionophores into proteoliposomes reconstituted with rat liver P-glycoprotein. 
  • Verapamil effects on physiological and behavioral responses to ethanol in the rat. 
  • Verapamil prolongs atrial fibrillation by evoking an intense sympathetic neurohumoral effect. 
  • Verapamil suppresses d-amphetamine-induced place preference conditioning.